Publications
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial2012 | First Faculty of Medicine
- Escalating therapy in multiple sclerosis2012 | First Faculty of Medicine
- The clinical standard for the diagnosis and treatment of multiple sclerosis and neuromyelitis optica2012 | First Faculty of Medicine
- Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome2012 | First Faculty of Medicine
- Interferon-beta or azathioprine as add-on therapies in patients with active multiple sclerosis2012 | First Faculty of Medicine
- Current treatment options in multiple sclerosis2011 | First Faculty of Medicine
- Risks of Immune System Treatments2010 | First Faculty of Medicine
- Current therapeutic options for multiple sclerosis2010 | First Faculty of Medicine
- Freedom from disease activity in multiple sclerosis2010 | First Faculty of Medicine
- Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis2009 | First Faculty of Medicine
Loading network view...